We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

7912:TSEDai Nippon Printing Co., Ltd. Analysis

Data as of 2026-05-18 - not real-time

¥2,815.50

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Dai Nippon Printing is trading at ¥2,815.5, comfortably above its 20‑day SMA of ¥3,022.6 and 50‑day SMA of ¥2,983.5, with a bullish trend direction but a MACD histogram that remains in bearish territory (‑22.3) and an RSI of 40 indicating neither overbought nor oversold conditions. The stock sits near its calculated support of ¥2,797.5 and faces resistance around ¥3,279, while volume is on an increasing trend, suggesting accumulating interest. Fundamentally, the price appears stretched as the DCF‑derived fair value is only ¥1,003, implying an overvaluation despite a low trailing PE of 11.96 versus an industry average of 29.6. The company offers a modest dividend yield of 1.41% with a low payout ratio of 17%, supporting dividend sustainability. Revenue growth is flat at 1.5% and margins are modest (gross 24%, operating 6.4%), with ROE at 8.6% and a high debt‑to‑equity of 20.8, while free cash flow is negative. Recent news of a new decorative film rollout in China could provide a growth catalyst, but the high leverage and negative free cash flow temper optimism.
Overall, the stock combines a technically bullish backdrop with fundamental concerns around valuation, cash generation, and debt, leading to a cautious stance despite the attractive dividend and low beta (0.34). The elevated 30‑day volatility (≈51%) and sector‑specific risks suggest the need for careful risk management, while the extreme greed sentiment in the market may be inflating price expectations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with increasing volume
  • MACD histogram still bearish, limiting upside
  • Attractive dividend yield with low payout

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Modest revenue growth and solid gross margins
  • High debt‑to‑equity ratio and negative free cash flow
  • Valuation gap between market price and DCF fair value

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Significant overvaluation relative to intrinsic value
  • Persistent leverage and cash‑flow constraints
  • Potential upside from new product rollout may be insufficient to justify current price

Key Metrics & Analysis

Financial Health

Revenue Growth1.50%
Profit Margin6.87%
P/E Ratio12.0
ROE8.63%
ROA3.20%
Debt/Equity20.80
P/B Ratio1.1
Op. Cash Flow¥40.4B
Free Cash Flow¥-5850124800
Industry P/E29.6

Technical Analysis

TrendBullish
RSI40.2
Support¥2,797.50
Resistance¥3,279.00
MA 20¥3,022.65
MA 50¥2,983.49
MA 200¥2,719.72
MACDBearish
VolumeIncreasing
Fear & Greed Index86.8

Valuation

Fair Value¥1,002.69
Target Price¥3,150.00
Upside/Downside11.88%
GradeOvervalued
TypeValue
Dividend Yield1.41%

Risk Assessment

Beta0.34
Volatility51.04%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.